{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:36:18Z","timestamp":1793118978899,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40123-025-01214-y","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T02:37:53Z","timestamp":1755571073000},"page":"2481-2496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of 0.01% Atropine Eye Drops and Novel Lenslet-ARray-Integrated Spectacle Lenses for the Prevention of Myopia Progression Among Children with Premyopia: A Randomized Clinical Trial"],"prefix":"10.1007","volume":"14","clinical-trial-number":[{"clinical-trial-number":"chictr2500098887","registry":"10.18810\/chictr"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-713X","authenticated-orcid":false,"given":"Mingjun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2448-064X","authenticated-orcid":false,"given":"Yanhua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3005-4480","authenticated-orcid":false,"given":"Yutong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7208-8158","authenticated-orcid":false,"given":"Zhanhua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-2722","authenticated-orcid":false,"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"3","key":"1214_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1177\/1120672121998960","volume":"31","author":"J N\u00e9meth","year":"2021","unstructured":"N\u00e9meth J, Tapaszt\u00f3 B, Aclimandos WA, et al. Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. Eur J Ophthalmol. 2021;31(3):853\u201383. https:\/\/doi.org\/10.1177\/1120672121998960.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"1214_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology"},{"issue":"3","key":"1214_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/IAE.0000000000002590","volume":"40","author":"L Dong","year":"2020","unstructured":"Dong L, Kang YK, Li Y, et al. Prevalence and time trends of myopia in children and adolescents in China: a systemic review and meta-analysis. Retina. 2020;40(3):399\u2013411. https:\/\/doi.org\/10.1097\/IAE.0000000000002590.","journal-title":"Retina"},{"key":"1214_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","volume":"138","author":"Y Hu","year":"2020","unstructured":"Hu Y, Ding XH, Guo XX, et al. Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese Cohort. JAMA Ophthalmol. 2020;138:1129\u201334. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3451.","journal-title":"JAMA Ophthalmol"},{"key":"1214_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/aos.13964","volume":"97","author":"O Parssinen","year":"2019","unstructured":"Parssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol. 2019;97:510\u20138. https:\/\/doi.org\/10.1111\/aos.13964.","journal-title":"Acta Ophthalmol"},{"key":"1214_CR6","doi-asserted-by":"publisher","unstructured":"IMI\u2014defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20\u2013M30. https:\/\/doi.org\/10.1167\/iovs.18-25957.","DOI":"10.1167\/iovs.18-25957"},{"key":"1214_CR7","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","volume":"48","author":"DO Mutti","year":"2007","unstructured":"Mutti DO, Hayes JR, Mitchell GL, et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007;48:2510\u20139. https:\/\/doi.org\/10.1167\/iovs.06-0562.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1214_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.ophtha.2012.01.017","volume":"119","author":"F Xiang","year":"2012","unstructured":"Xiang F, He MG, Morgan IG. Annual changes in refractive errors and ocular components before and after the onset of myopia in Chinese children. Ophthalmology. 2012;119:1478\u201384. https:\/\/doi.org\/10.1016\/j.ophtha.2012.01.017.","journal-title":"Ophthalmology"},{"key":"1214_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye. 2019;33:3\u201313. https:\/\/doi.org\/10.1038\/s41433-018-0139-7.","journal-title":"Eye"},{"key":"1214_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ophtha.2020.10.040","volume":"128","author":"BS Modjtahedi","year":"2021","unstructured":"Modjtahedi BS, Abbott RL, Fong DS, et al. Reducing the global burden of myopia by delaying the onset of myopia and reducing myopic progression in children: the academy\u2019s task force on myopia. Ophthalmology. 2021;128:816\u201326. https:\/\/doi.org\/10.1016\/j.ophtha.2020.10.040.","journal-title":"Ophthalmology"},{"key":"1214_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, et al. Efficacy in myopia control. Prog Retin Eye Res. 2021;83: 100923. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100923.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"1214_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","volume":"314","author":"M He","year":"2015","unstructured":"He M, Xiang F, Zeng Y, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA. 2015;314(11):1142\u20138. https:\/\/doi.org\/10.1001\/jama.2015.10803.","journal-title":"JAMA"},{"issue":"4","key":"1214_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123(4):697\u2013708. https:\/\/doi.org\/10.1016\/j.ophtha.2015.11.010.","journal-title":"Ophthalmology"},{"issue":"6","key":"1214_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/aos.13403","volume":"95","author":"S Xiong","year":"2017","unstructured":"Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017;95(6):551\u201366. https:\/\/doi.org\/10.1111\/aos.13403.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1214_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology. 2012;119(2):347\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031.","journal-title":"Ophthalmology"},{"issue":"11","key":"1214_CR16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"138","author":"S Wei","year":"2020","unstructured":"Wei S, Li SM, An W, et al. Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial. JAMA Ophthalmol. 2020;138(11):1178\u201384. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3820.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"1214_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/jop.2009.0135","volume":"26","author":"PC Fang","year":"2010","unstructured":"Fang PC, Chung MY, Yu HJ, et al. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010;26(4):341\u20135. https:\/\/doi.org\/10.1089\/jop.2009.0135.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"1214_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/ijo.IJO_1462_21","volume":"70","author":"J Jethani","year":"2022","unstructured":"Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol. 2022;70(1):238\u201340. https:\/\/doi.org\/10.4103\/ijo.IJO_1462_21.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"1214_CR19","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00431-023-04921-5","volume":"182","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang F, Yu S, et al. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children\u2014a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr. 2023;182(6):2597\u2013606. https:\/\/doi.org\/10.1007\/s00431-023-04921-5.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1214_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140(5):472\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"1214_CR21","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077\u201385. https:\/\/doi.org\/10.1167\/iovs.12-10565.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1214_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1214_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/opo.12332","volume":"37","author":"SM Li","year":"2017","unstructured":"Li SM, Kang MT, Wu SS, et al. Studies using concentric ring bifocal and peripheral add multifocal contact lenses to slow myopia progression in school-aged children: a meta-analysis. Ophthalmic Physiol Opt. 2017;37(1):51\u20139. https:\/\/doi.org\/10.1111\/opo.12332.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1214_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.07.002","author":"B Su","year":"2024","unstructured":"Su B, Cho P, Vincent SJ, et al. Novel Lenslet-ARray-integrated spectacle lenses for myopia control: a 1-year randomized, double-masked, controlled trial. Ophthalmology. 2024. https:\/\/doi.org\/10.1016\/j.ophtha.2024.07.002.","journal-title":"Ophthalmology"},{"key":"1214_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102317","author":"X Cao","year":"2024","unstructured":"Cao X, Guo Z, Wei Z, et al. Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children. Cont Lens Anterior Eye. 2024. https:\/\/doi.org\/10.1016\/j.clae.2024.102317.","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"1214_CR26","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","volume":"60","author":"CF Wildsoet","year":"2019","unstructured":"Wildsoet CF, Chia A, Cho P, et al. IMI\u2014Interventions Myopia Institute: interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci. 2019;60(3):M106\u201331. https:\/\/doi.org\/10.1167\/iovs.18-25958.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1214_CR27","doi-asserted-by":"publisher","unstructured":"He X, Wang J, Zhu Z, et al. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial [published correction appears in JAMA Netw Open. 2023 Sep 5;6(9):e2337652. 10.1001\/jamanetworkopen.2023.37652.].\u00a0JAMA Netw Open. 2023;6(4):e239612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.9612.","DOI":"10.1001\/jamanetworkopen.2023.9612"},{"issue":"3","key":"1214_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40123-023-00875-x","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun Z, Du B, et al. The effects of repeated low-level red-light therapy on the structure and vasculature of the choroid and retina in children with premyopia. Ophthalmol Ther. 2024;13(3):739\u201359. https:\/\/doi.org\/10.1007\/s40123-023-00875-x.","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"1214_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100115","volume":"14","author":"K Xiang","year":"2025","unstructured":"Xiang K, Wang J, Zhu Z, et al. Changes in choroidal thickness in pre-myopic children after repeated low-level red-light therapy and their role in predicting myopia prevention and controlling myopic shift. Asia Pac J Ophthalmol (Phila). 2025;14(2): 100115. https:\/\/doi.org\/10.1016\/j.apjo.2024.100115.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"12","key":"1214_CR30","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s40123-024-01059-x","volume":"13","author":"P Viggiano","year":"2024","unstructured":"Viggiano P, Boscia G, Borrelli E, et al. Micropulse laser versus eplerenone for chronic central serous chorioretinopathy: a 12-month comparison. Ophthalmol Ther. 2024;13(12):3175\u201388. https:\/\/doi.org\/10.1007\/s40123-024-01059-x.","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"1214_CR31","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/jcm13051506","volume":"13","author":"SH Lee","year":"2024","unstructured":"Lee SH, Tseng BY, Wang JH, et al. Efficacy and safety of low-dose atropine on myopia prevention in premyopic children: systematic review and meta-analysis. J Clin Med. 2024;13(5):1506. https:\/\/doi.org\/10.3390\/jcm13051506.","journal-title":"J Clin Med"},{"key":"1214_CR32","doi-asserted-by":"publisher","unstructured":"Yam JC, Zhang XJ, Zhang Y, et al. Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial [published correction appears in JAMA. 2023;329(13):1123. https:\/\/doi.org\/10.1001\/jama.2022.24162.","DOI":"10.1001\/jama.2022.24162"},{"issue":"8","key":"1214_CR33","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bjophthalmol-2020-317664","volume":"106","author":"CS Lam","year":"2022","unstructured":"Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106(8):1110\u20134. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317664.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1214_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/eye.2013.256","volume":"28","author":"B Holden","year":"2014","unstructured":"Holden B, Sankaridurg P, Smith E, Aller T, Jong M, He M. Myopia, an underrated global challenge to vision: where the current data takes us on myopia control. Eye (Lond). 2014;28(2):142\u20136. https:\/\/doi.org\/10.1038\/eye.2013.256.","journal-title":"Eye (Lond)"},{"issue":"5","key":"1214_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng AL, Choy BN, et al. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt. 2020;40(5):557\u201366. https:\/\/doi.org\/10.1111\/opo.12722.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1214_CR36","doi-asserted-by":"publisher","first-page":"1460156","DOI":"10.3389\/fpubh.2024.1460156","volume":"12","author":"C Lanca","year":"2024","unstructured":"Lanca C, Pang CP, Grzybowski A. Corrigendum: effectiveness of myopia control interventions: a systematic review of 12 randomized control trials published between 2019 and 2021. Front Public Health. 2024;12:1460156. https:\/\/doi.org\/10.3389\/fpubh.2024.1460156.","journal-title":"Front Public Health"},{"issue":"1","key":"1214_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1167\/iovs.04-0565","volume":"46","author":"SM Saw","year":"2005","unstructured":"Saw SM, Tong L, Chua WH, et al. Incidence and progression of myopia in Singaporean school children. Invest Ophthalmol Vis Sci. 2005;46(1):51\u20137. https:\/\/doi.org\/10.1167\/iovs.04-0565.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1214_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.64.6.4","volume":"64","author":"LA Ostrin","year":"2023","unstructured":"Ostrin LA, Harb E, Nickla DL, et al. IMI\u2014the dynamic choroid: new insights, challenges, and potential significance for human myopia. Invest Ophthalmol Vis Sci. 2023;64(6):4. https:\/\/doi.org\/10.1167\/iovs.64.6.4.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1214_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115542","volume":"167","author":"K Thomson","year":"2023","unstructured":"Thomson K, Karouta C, Weber D, et al. The role of the serotonergic system in atropine\u2019s anti-myopic effects. Biomed Pharmacother. 2023;167: 115542. https:\/\/doi.org\/10.1016\/j.biopha.2023.115542.","journal-title":"Biomed Pharmacother"},{"key":"1214_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","volume":"237","author":"JC Yam","year":"2022","unstructured":"Yam JC, Jiang Y, Lee J, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study. Am J Ophthalmol. 2022;237:130\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2021.12.014.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"1214_CR41","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","volume":"41","author":"Q Hao","year":"2021","unstructured":"Hao Q, Zhao Q. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination. Int Ophthalmol. 2021;41(9):2963\u201371. https:\/\/doi.org\/10.1007\/s10792-021-01855-5.","journal-title":"Int Ophthalmol"},{"issue":"14","key":"1214_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.14.15","volume":"61","author":"L Ye","year":"2020","unstructured":"Ye L, Shi Y, Yin Y, et al. Effects of atropine treatment on choroidal thickness in myopic children. Invest Ophthalmol Vis Sci. 2020;61(14):15. https:\/\/doi.org\/10.1167\/iovs.61.14.15.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1214_CR43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jfo.2020.04.023","volume":"43","author":"W Li","year":"2020","unstructured":"Li W, Jiang R, Zhu Y, et al. Effect of 0.01% atropine eye drops on choroidal thickness in myopic children. J Fr Ophtalmol. 2020;43(9):862\u20138. https:\/\/doi.org\/10.1016\/j.jfo.2020.04.023.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1214_CR44","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40123-022-00476-0","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu X, Xuan Y, et al. Short-term effects of atropine 0.01% on the structure and vasculature of the choroid and retina in myopic Chinese children. Ophthalmol Ther. 2022;11(2):833\u201356. https:\/\/doi.org\/10.1007\/s40123-022-00476-0.","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"1214_CR45","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s40123-024-01051-5","volume":"13","author":"NC Hansen","year":"2024","unstructured":"Hansen NC, Hvid-Hansen A, Bek T, et al. The macular choroidal thickness in Danish children with myopia after two-year low-dose atropine and one-year wash-out: a placebo-controlled, randomized clinical trial. Ophthalmol Ther. 2024;13(12):3111\u201322. https:\/\/doi.org\/10.1007\/s40123-024-01051-5.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1214_CR46","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/aos.13866","volume":"97","author":"Z Li","year":"2019","unstructured":"Li Z, Hu Y, Cui D, et al. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length. Acta Ophthalmol. 2019;97(3):e454\u20139. https:\/\/doi.org\/10.1111\/aos.13866.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1214_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-002059","volume":"10","author":"N Ghorbani-Mojarrad","year":"2025","unstructured":"Ghorbani-Mojarrad N, Han X, Dbayat N, et al. What do we know about premyopia and should we be giving it greater consideration? BMJ Open Ophthalmol. 2025;10(1): e002059. https:\/\/doi.org\/10.1136\/bmjophth-2024-002059.","journal-title":"BMJ Open Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01214-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01214-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01214-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:41:03Z","timestamp":1757068863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01214-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01214-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mingjun Gao, Yanhua Hou, Yutong Lu, Zhanhua Shi, and Qi Zhao have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study followed the principles of the Declaration of Helsinki and was approved by the institutional review board of The Second Hospital of Dalian Medical University (KY2024-206-01). The trial was registered in the Chinese Clinical Trial Registry () with the registration number ChiCTR2500098887 due to unavoidable post-pandemic institutional review backlog and administrative complexities beyond control. Despite retrospective registration, the pre-specified statistical analysis plan was adhered to, and there were no changes in the protocol and methods after trial commencement. All outcomes registered match those reported. The trial original protocol is available in the Supplementary Material. For subjects under 8\u00a0years of age, we obtained informed written consent from their legal guardians. For subjects aged\u2009\u2265\u20098\u00a0years, we obtained the informed consent of the subjects themselves and their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}